Skip to main navigation
logo
follow us: facebooktwitterlinkedininstagram
Menu - Navigation
  • About
    • Our Mission
    • Our Team
    • Board of Directors
    • Sustainability
    • Press Releases
    • Site Administrator
  • Animal Health
    • Animal Health Product Pipeline
    • Prescription Products
    • Non-Prescription Products
  • Neonorm
    • Learn about Neonorm Calf
    • Learn about Neonorm Foal
  • Partnering
  • Investors & News
  • Blog
  • Media
  • Contact
  • Shop

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • News Releases
  • Events & Presentations
  • SEC Filings
  • STOCKHOLDER MEETINGS AND PROXY MATERIALS
  • Corporate Governance
  • Contact Jaguar IR

Events & Presentations

There are no items to display.

Upcoming Events

There are currently no events to display.

Archived Events

  • Jaguar Health Company Updates Conference Call
    Nov 15, 2018 at 8:00 AM EST
    Webcast
    Click here for webcast
  • Jaguar Health Company Updates Conference Call
    May 21, 2018 at 4:30 PM EDT
    Webcast
    Click here for webcast
  • Jaguar Health Company Updates Conference Call
    Jan 22, 2018 at 4:15 PM EST
    Webcast
    Click here for webcast
  • Jaguar Health Earnings Conference Call
    Nov 14, 2017 at 5:45 PM EST
    Webcast
    Click here for webcast
  • Jaguar Health: Jaguar Animal Health & Napo Pharmaceuticals Merger Update
    Jul 28, 2017 8:30 AM EDT
    Webcast
    Click here for webcast

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
© Copyright 2017 Jaguar Health

Jaguar Health, our logo, Canalevia and Neonorm are our trademarks that are used in this website. Mytesi is a registered trademark of Napo Pharmaceuticals, Inc. This website also includes trademarks, tradenames and service marks that are the property of other organizations. Solely for convenience, trademarks and tradenames referred to in this website appear without the ™ and ® symbols, but those references are not intended to indicate that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trademarks and tradenames.

Home | Contact Us | Careers | Login |